Exercise-Regulated Adipokines for Diabetes Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating diabetes and glucose metabolism are limited, with a lack of understanding of native physiological pathways and factors that mediate glucose control and metabolism, particularly in individuals with type II diabetes.
Innovation Solution
Identification and regulation of adipokines secreted by exercise-trained adipose tissue that mediate cross-talk between adipose tissue and other tissues, such as skeletal muscle and liver, to improve glucose control, insulin sensitivity, and metabolic health.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If exercise training is used to modulate glucose metabolism, then glucose control and insulin sensitivity are improved, but the physiological basis and specific factors mediating these effects are not well understood
Solution Approach 1:
The patent identifies adipokines as intermediary molecules that mediate the communication between adipose tissue and other tissues during exercise. These adipokines serve as the missing link that explains how exercise training translates into improved glucose metabolism, providing the physiological basis that was previously unknown.
Solution Approach 2:
The patent replaces the mechanical exercise intervention with a molecular-level approach by identifying and characterizing specific adipokine molecules. This substitution allows for precise identification of the physiological factors without requiring continuous mechanical exercise, enabling targeted therapeutic development.
2Reliability
If adipose tissue transplantation is performed, then glucose tolerance and insulin sensitivity are significantly improved, but the specific mechanisms and factors involved are not fully identified
Solution Approach 1:
The patent extracts and identifies specific adipokine molecules from adipose tissue that are responsible for the beneficial effects of transplantation. By isolating these specific factors (such as TGFβ2 and Wnt3a), the research transitions from observing general tissue effects to identifying precise molecular mediators.
Solution Approach 2:
The patent creates a model system by transplanting exercise-trained adipose tissue into sedentary recipients, effectively copying the metabolic benefits of exercise into a controllable experimental system. This allows for the detection and measurement of specific mediating factors that would be difficult to observe in natural exercise scenarios.
3Reliability
If current diabetes treatment methods are used, then some glucose control is achieved, but treatment options are limited and do not address underlying physiological pathways
Solution Approach 1:
The patent changes the fundamental parameter of diabetes treatment from symptomatic management to pathway-specific intervention. By identifying specific adipokines and their signaling pathways, the research enables targeted therapies that modify the underlying physiological parameters rather than merely controlling blood glucose levels.
Solution Approach 2:
The patent reveals that adipokines have multiple functions including modulation of glucose metabolism, inflammation control, and insulin sensitivity. This multi-functionality provides versatile treatment options that can address multiple aspects of diabetes pathology simultaneously, expanding beyond current single-target therapies.
Data Source
AI summary
The present invention is related to methods and compositions effective in regulating glycemic control in subject individuals in need of the regulation of glycemic control. Said individuals may have diabetes or be prediabetic condition receive therapeutically effective amounts of identified secreted proteins in an amount suitable for modulating glycemic control and to thereby treat or prevent diabetes in said subject.